
Qualia Oto is a biomedical device company focused on advancing auditory technologies, particularly cochlear implants. Founded in 2017 based on research from its co-founders, the company utilizes novel shape-changing polymers and multiplexed TFT arrays for improved neural interface applications. Their materials are biocompatible and soften at body temperature, allowing for easier implantation and reduced tissue scarring. The TFT arrays enable a higher density of electrodes for more precise auditory nerve stimulation, with potential for machine learning integration. Qualia Oto has secured significant grant funding, including from the NIH, to validate its technologies and has garnered industry recognition through presentations and publications. The company aims to address the growing global need for solutions for disabling hearing loss.

Qualia Oto is a biomedical device company focused on advancing auditory technologies, particularly cochlear implants. Founded in 2017 based on research from its co-founders, the company utilizes novel shape-changing polymers and multiplexed TFT arrays for improved neural interface applications. Their materials are biocompatible and soften at body temperature, allowing for easier implantation and reduced tissue scarring. The TFT arrays enable a higher density of electrodes for more precise auditory nerve stimulation, with potential for machine learning integration. Qualia Oto has secured significant grant funding, including from the NIH, to validate its technologies and has garnered industry recognition through presentations and publications. The company aims to address the growing global need for solutions for disabling hearing loss.